Stock Taper 
JAN
$30.50
▼ DOWN 0.68% (-0.21)
KEY STATISTICS
Market Cap$6.47 B
52w High$32.83
52w Low$22.76
Dividend Yield1.05%
FrequencyMonthly
P/E-667.40
Volume575.83K
Shares Out.212.22M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Scott Brinker
ABOUT
SECTOR
Real Estate
WENT PUBLIC
March 20, 2026
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
5
PRICE TARGET
Target High$34.00
Target Low$27.00
Target Median$30.00
Target Consensus$30.64
UPCOMING EARNINGS
DateNov 3, 2026
DayTuesday
Rev. Est.$239.31M
NOV
3
TUE
PRICE
$30.50 ▼ DOWN 0.68% (−$0.21)About Janus Living, Inc.
http://janusreit.com ↗JanOne Inc. is a clinical-stage biopharmaceutical company developing non-opioid, non-addictive therapies like its lead product JAN101 for pain and blood flow issues related to diabetes and peripheral artery disease.
INDUSTRY
REIT - Diversified
A PRODUCT JANUS LIVING, INC. IS KNOWN FOR
Life Plan Communities
Janus Living owns 34 Life Plan Communities in Florida and Texas, offering high-quality senior housing with a full continuum of care—from independent living to skilled nursing—on a single campus to attract long-term residents.
Revenue by Products
| Icon | PRODUCT | Q1-2026 | Q2-2026 |
|---|---|---|---|
 | Resident Fees and Services | $200.34M | $216.46M ▲ |
RATINGS SNAPSHOT
Overall rating: C
Discounted Cash Flow4
Return On Equity2
Return On Assets2
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2
INSIDER TRADES
★
DIRECTOR
Sandstrom Katherine M
Purchase · 13.5K shares
2026-03-23
★
OFFICER: CHIEF FINANCIAL OFFICER
Moses Kelvin O
Purchase · 15.0K shares
2026-03-23
★
DIRECTOR
HERMAN CHARLES J JR
Purchase · 5.0K shares
2026-03-23
★
DIRECTOR
HERMAN CHARLES J JR
Purchase · 2.5K shares
2026-03-23
MOST RECENT ANALYST GRADES
GRADE SUMMARY
OVERWEIGHT 6
OUTPERFORM 1
SECTOR OUTPERFORM 1
8 GRADES IN THE LAST 12 MONTHS
